NexturnBioscience Co. Ltd (089140) — Free Cash Flow Generation Index
NexturnBioscience Co. Ltd (089140) has a Free Cash Flow Generation Index of 0.94x as of September 2025. Free cash flow of ₩4.23 Billion represents 1% of operating cash flow (₩4.51 Billion). Explore 089140 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
NexturnBioscience Co. Ltd Free Cash Flow Generation Index (2007–2021)
Historical FCF Generation Index trend for NexturnBioscience Co. Ltd across 12 annual periods. For the full cash flow conversion analysis, see 089140 cash flow metrics.
Annual Free Cash Flow Generation for NexturnBioscience Co. Ltd (2007–2021)
Year-by-year Free Cash Flow Generation Index for NexturnBioscience Co. Ltd. Check 089140 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.87x | ₩3.18 Billion | ₩3.66 Billion | ₩467.60 Million | ▲ +14.4% |
| 2020 | 0.76x | ₩178.75 Million | ₩235.94 Million | ₩1.21 Billion | ▼ -90.2% |
| 2019 | 7.72x | ₩21.12 Billion | ₩2.74 Billion | ₩18.38 Billion | ▲ +656.5% |
| 2018 | 1.02x | ₩9.83 Billion | ₩9.63 Billion | ₩199.42 Million | ▼ -12.9% |
| 2017 | 1.17x | ₩5.95 Billion | ₩5.08 Billion | ₩870.45 Million | ▲ +11.5% |
| 2016 | 1.05x | ₩18.77 Billion | ₩17.88 Billion | ₩893.46 Million | ▼ -28.7% |
| 2015 | 1.47x | ₩2.82 Billion | ₩1.92 Billion | ₩906.54 Million | ▲ +47.1% |
| 2014 | 1.00x | ₩6.49 Billion | ₩6.48 Billion | ₩8.97 Million | ▼ -83.7% |
| 2010 | 6.15x | ₩1.45 Billion | ₩235.94 Million | ₩1.21 Billion | ▲ +475.7% |
| 2009 | 1.07x | ₩1.07 Billion | ₩998.03 Million | ₩68.11 Million | ▼ -11.6% |
| 2008 | 1.21x | ₩1.14 Billion | ₩945.34 Million | ₩197.16 Million | ▼ -56.1% |
| 2007 | 2.75x | ₩6.23 Billion | ₩2.26 Billion | ₩3.97 Billion | — |